Stock 9SO SOLASIA PHARMA K.K.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Solasia Pharma K.K. Deutsche Boerse AG

Equities

9SO

JP3436500007

Delayed Deutsche Boerse AG
Other stock markets
 09:31:46 03/06/2024 BST 		5-day change 1st Jan Change
0.139 EUR 0.00% Intraday chart for Solasia Pharma K.K. -7.95% -48.13%
05-15 Solasia Pharma K.K. Provides Consolidated Earnings Forecasts for the Fiscal Year Ending December 31, 2024 CI
03-04 Solasia Pharma K.K. announced that it has received KRW 504.33 million in funding from Macquarie Group Limited CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ELI LILLY AND COMPANY Stock Eli Lilly and Company
 739B
NOVO NORDISK A/S Stock Novo Nordisk A/S
 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
 318B
ABBVIE INC. Stock AbbVie Inc.
 285B
  1. Stock Market
  2. Equities
  3. 4597 Stock
  4. 9SO Stock
  5. Charts Solasia Pharma K.K.
  6. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW